Trump is changing Medicare, mostly focusing on providers. But the biggest impact may come from tariffs and deporting ...

Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...

The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...

Several companies, including Oracle and Microsoft, are expected to sign pledges to work on the Trump administration ...

People who get subsidized coverage through what’s known as Medicare Savings Programs get to keep hundreds of dollars per ...

Obesity drugmakers Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) traded higher in the premarket on Friday after The Washington ...

Republicans lambasted Democrats last year for subsidizing monthly payments that seniors pay for prescription drug insurance, ...

For those of us who live in rural communities, the $1.02 trillion cut to Medicaid in the new law will not only cut off access to affordable healthcare by decimating coverage and forcing the closure of ...

Washington Post National Health Reporter Paige Winfield Cunningham discusses how the Trump administration is considering ...